Human MafG is a functional partner for p45 NF-E2 in activating globin gene expression

Area of Science:

• Molecular Biology
• Hematology
• Gene Regulation

Background:

• Mammalian globin gene expression relies on NF-E2 elements, recognized by AP-1 superfamily proteins.
• Transcription factor specificity is influenced by nucleotides adjacent to the AP-1 motif, involving Maf subfamily factors.
• Previous studies suggested p18(MafK) heterodimerizes with p45 NF-E2, but in vivo evidence was lacking.

Purpose of the Study:

• To identify and characterize the human homolog of chicken MafG.
• To determine if human MafG can functionally partner with p45 NF-E2.
• To investigate the role of the p45/MafG heterodimer in globin gene expression and erythroid differentiation.

Main Methods:

• Cloning and characterization of a novel human MafG cDNA.
• Heterodimerization assays between human MafG and p45 NF-E2.
• DNA binding specificity analysis of the p45/MafG complex.
• Functional studies in a p45-deficient erythroleukemia cell line (CB3) assessing globin expression and erythroid differentiation.

Main Results:

• A novel human cDNA encoding MafG was identified.
• Human MafG heterodimerizes with p45 NF-E2, exhibiting identical DNA binding specificity to purified NF-E2 activity.
• A p45/MafG heterodimer fully supported alpha- and beta-globin expression and promoted erythroid differentiation in CB3 cells.

Conclusions:

• Human MafG serves as a functional partner for p45 NF-E2.
• The p45/MafG heterodimer is implicated in the regulation of erythropoiesis.
• This finding provides direct evidence for MafG's role in regulating globin gene expression and red blood cell development.